This Heart Month Dr. Bruce T. Liang, director of UConn Health’s Pat and Jim Calhoun Cardiology Center and dean of the UConn School of Medicine, is sharing his
Using the immunosuppressant medication methotrexate to treat psoriasis and psoriatic arthritis is more likely to lead to serious liver complications than using the same medication to treat rheumatoid
People with periodontitis are at higher risk of experiencing major cardiovascular events, according to new research from Forsyth Institute and Harvard University scientists and colleagues. In a longitudinal
A 50-year-old white male doctor in the Northeast, earning more than $200,000, is more than seven times likely to be vaccinated than a 45-year-old Black female nursing assistant
After what has felt like the longest and most challenging lockdown yet, Boris Johnson is set to reveal how we’re getting out of this. The government is finally
England’s salt reduction program will have led to nearly 200,000 fewer adults developing heart disease and £1.64 billion of healthcare cost savings by 2050, according to research by
Australia started its COVID-19 inoculation program on Monday, days after its neighbor New Zealand, with both governments deciding their pandemic experiences did not require the fast tracking of
The delivery to Guinea of vaccines against the Ebola virus has been delayed because of fog disrupting flights to the capital Conakry, a health official said Sunday. The
Creating “super soldiers” of specific white blood cells to boost an anti-tumor response has been shown in a series of elegant experiments by Princess Margaret researchers. Research led
Researchers from the UPC’s Molecular Biotechnology Centre show that a drug for osteoporosis called raloxifene may inhibit molecules involved in the inflammatory processes associated with COVID-19. About 20%
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
